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INTRODUCTION:  Hepatocellular  carcinoma  (HCC)  in  ectopic  liver  tissue  is  extremely  rare.
PRESENTATION  OF  CASE:  A  64-year-old  woman  presented  initially  with  abdominal  complaints.  Computed
tomography  (CT)  revealed  a tumor  in  the diaphragm  and  laparoscopic  resection  of  the  tumor  was  per-
formed.  Histology  showed  HCC.  During  the  next 4  years  four more  tumors,  all  of  which  showed  HCC
on  histology  and  were  located  extrahepatically,  was  treated  with  laparoscopic  resection.  During  this
course  the  patient  was  followed  with  regular  thoracoabdominal  CT and measurement  of  serum  alpha-
fetoprotein  (AFP).  A negative  magnetic  resonance  imaging  (MRI)  examination  of  the  liver excluded  a
primary  intrahepatic  tumor.
DISCUSSION:  The  literature  available  on  ectopic  HCC  and  the guidelines  for management  of HCC  do  not
address  the  postoperative  surveillance  of patients  undergoing  curative  treatment.  A follow-up  regime  has
been proposed  by  Hatzaras  et  al.  (2014)  to include  cross-sectional  imaging  of  the  liver and  measurement
of  serum  AFP  levels  [1].  CT  would  be  the  preferred  study  of  choice  in  a total  radiologic  investigation  of
the  abdomen.  While  MRI  is  prone  to  artifacts  due to movements,  CT  scans  allows  so rapid  recordings  that
this  no longer  is  an  issue.  An early  investigation  of the  liver  for intrahepatic  HCC  should  nevertheless  be
performed  early  to exclude  primary  intrahepatic  HCC.
CONCLUSION:  We  recommend  that patients  with  ectopic  HCC  should  be followed  every 6  months  with
measurement  of  AFP  and  abdominal  CT  imaging.  MRI  of the  liver  should  be  performed  early  to exclude
primary  intrahepatic  HCC.
© 2015  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Ectopic liver tissue derives from a developmental anomaly due
o aberrant hepatic tissue migration [2], and is incidentally encoun-
ered by laparoscopy, laparotomy or autopsy. The prevalence of
xtrahepatic liver tissue is reported between 0.24 and 0.47% [3,4].
epatocellular carcinoma (HCC) in ectopic liver tissue is extremely
are. Including our patient, a total of 60 cases have been reported
5]. Ectopic liver tissue seems to be prone to development of HCC
nd various theories have been made to explain the development
f HCC in ectopic liver tissue [2,6,7]. The presentation of an ectopic
∗ Corresponding author.
E-mail address: trulsagjersoe@gmail.com (T.A. Reitan-Gjersøe).
ttp://dx.doi.org/10.1016/j.ijscr.2015.10.014
210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
HCC varies from acute abdominal crisis caused by rupture of the
tumor to incidental ﬁnding on routine medical investigations. Sur-
gical resection is the preferred treatment and may be curative.
Laparoscopic resection has been reported with successful outcome
[5,8]. Postoperative follow-up for potential recurrence of ectopic
HCC has not been established and reported follow-up programs
vary.
We present a patient with recurrent ectopic HCC handled by
repeated laparoscopic resections. We  also make recommendations
for postoperative surveillance based on guidelines for follow-up
after resection of intrahepatic HCC and a review of the literature.Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Preoperative CT image of the ﬁrst tumour. Axial view.
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rFig. 2. Preoperative CT image
.1. Presentation of case
A 64-year-old Asian woman with no history of previous hepatic
isease presented with atypical abdominal complaints. Abdom-
nal computed tomography (CT) revealed a tumor in the upper
eft abdominal quadrant (Figs. 1 and 2). The tumor was initially
hought to originate from the gastric fundus, but following gas-
roscopy compression from a tumor located outside the stomach
as suspected. Serum alpha-fetoprotein (AFP) was  200 ng/ml.
aparoscopic resection of a 35 × 25 × 10 mm tumor located in the
iaphragm was performed. Although macroscopically radically
esected, microscopy revealed tumor tissue in the resection mar-
ins. It was histologically concluded that the patient had HCC
riginating from ectopic liver tissue. CT showed no liver pathology.
The postoperative period was uneventful. Two weeks later the
atient was examined with magnetic resonance imaging (MRI) of
he liver and a contrast enhanced ultrasound (US) without ﬁnd-
ngs of malignancy. Three weeks later the patient tested positive
or Hepatitis A and B virus antibodies, while Hepatitis C and HIV
ntibodies were negative. The Hepatitis B virus antigen was  nega-
ive. She then underwent a positron emission tomography (PET)-CT
nd there were no signs of viable tumor tissue. Control CT scans at
, 9, 14 and 22 months postoperative were all negative and the AFP
emained in the normal area.e ﬁrst tumour. Coronal view.
At 2 years her AFP levels had increased to 45 ng/ml and four
months later the AFP was 72 ng/ml. A CT scan did not show evi-
dence of liver pathology, but a 1 cm lymph node on the right side
of the abdomen near the falciform ligament was  detected. The
lymph node showed contrast enhancement in the arterial phase.
A repeat MRI  showed no sign of intracellular tumor uptake of
the hepatocyte-speciﬁc contrast medium gadolinium ethoxybenzyl
diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) (Primovist,
Bayer healthcare). US guided ﬁne needle aspiration cytology (FNAC)
of the extrahepatic lesion showed HCC cells.
Laparoscopic resection of the lymph node was made 30 months
after the initial resection. Preoperative AFP was 58 ng/ml. On gross
laparoscopic evaluation, the liver appeared normal with no signs
of cirrhosis or focal lesions. No other lesions were observed in the
peritoneal cavity. In the falciform ligament, in close proximity to
the round ligament of the liver, an umbilication of the ligament
could be seen. The lesion was  resected, with macroscopically free
margins, and frozen sections of the lesion conﬁrmed the presence
of HCC.
Postoperatively the AFP level remained elevated at 47 ng/ml, but
CT 4 months later was  without pathology. Repeat thoracoabdomi-
nal CT scan 8 months after the second operation, revealed two  new
lesions in relation to the pylorus/duodenum suspicious of recurrent
disease. The diameters of the suspected lymph nodes were 10 mm
and 4 mm,  respectively. The AFP level had increased to 161 ng/ml.
CASE  REPORT  –  O
94 A.M. Aarås et al. / International Journal of Su
Table 1
Combinations of surveillance test used in case reports of ectopic HCC.
Authors Year Journal CT AFP US MRI
Takayasu K. et al. 1994 Clin. Radiol. X
Asselah T. et al. 2001 Eur. J. Gastroenterol. Hepatol. X X X
Iwase K. et al. 2001 J. Hepatobiliary Pancreat. Surg. X X
Kim  K.A. et al. 2003 Eur. Radiol. X
Leone N. et al. 2004 Eur. J. Gastroenterol. Hepatol. Xa,b Xa,b Xb
Shigemori M. et al. 2006 J. Gastroenterol. X X
Huang T.W. et al. 2007 Dig. Dis. Sci. X X
Steen S. et al. 2013 Clin. Case Rep. X X
Sooﬁ Y. et al. 2014 Diagn. Cytopathol. X X
Oldani A. et al. 2014 Ann. Ital. Chir. X X
Total 10 7 4 2
CT = Computed tomography, AFP = Alpha-fetoprotein, US = Ultrasonography,
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cRI  = Magnetic resonance imaging.
a Refers to case 1.
b Refers to case 2.
he patient underwent a third laparoscopic resection of the two
esions 1 month later. At surgery, the ﬁrst lesion was  located in
elation to the duodenal wall, immediately distal to the pylorus.
he lesion was partly necrotic and was meticulously dissected out
nd removed. The second lesion at the descending part of the duo-
enum was easily removed. Histology of the 2 lesions both showed
CC. On a subsequent thoracoabdominal CT 8 months after the
hird operation, a new lesion was detected in relation to the mid-
le colic artery. MRI  examination with Gd-EOB-DTPA did not show
igns of intracellular contrast uptake in the tumor. A fourth laparo-
copic resection was performed again of a topical extrahepatic HCC
onﬁrmed by histology. Upon further follow-up, she is now without
ny signs of disease almost four years after the initial resection.
. Discussion
Laparoscopic resection of intrahepatic HCC may  have short-
erm advantages compared to open surgery in blood loss and
ost-operative morbidity, but similar long-term outcome [9]. A
ecent meta-analysis by Xiong et al. concluded that laparoscopic
esection of intrahepatic HCC is a feasible and safe treatment [10].
ctopic HCCs are generally well-deﬁned anatomical structures.
his fact makes them amenable to laparoscopic curative resection
8]. The laparoscopic approach may  facilitate repeated resections.
n our patient the presence of minimal postoperative adhesions
llowed easy access to the recurrences during all three repeated
rocedures.
Available literature brings little evidence in regard to postoper-
tive follow-up following resection of ectopic HCC. In the total of
0 case reports since 1990, only ten case reports indicate the tests
pplied for surveillance (Table 1). For example Leone et al. describe
wo cases that are followed up differently: the ﬁrst one with CT
nd AFP and the second one with US, CT and AFP [7]. Table 1 also
emonstrates the great variation in the combination of tests used
or postoperative surveillance of ectopic HCC.
We  will in the following paragraphs present a rationale for opti-
al  postoperative surveillance and control of patients with ectopic
CC. This is based on the knowledge of the nature of HCC in intra-
epatic liver tissue and the deduced practical clinical guidelines for
anagement of intrahepatic HCC that we have reviewed.
We reviewed the clinical practical guidelines of the Asian-Paciﬁc
ssociation for the Study of the Liver [11], the American Association
or the Study of the Liver Diseases [12] and the European asso-
iation for the study of the liver [13] with focus on surveillance.
hese guidelines are based on screening of patients with chronic
iver disease and not on patients that underwent intended curative
reatment for HCC. Surveillance frequency and the test methods of
hoices are the same in the three guidelines, and consist of US ofPEN  ACCESS
rgery Case Reports 17 (2015) 92–95
the liver and AFP measurement every 6 months. The European and
American guidelines consider an AFP concentration ≥200 ng/ml
diagnostic for HCC.
US, CT and MRI  are all applied in the surveillance of intrahepatic
HCC. The beneﬁts of US is wide availability, low cost and lack of
ionizing radiation [14]. The drawbacks for using US  is a very vari-
able sensitivity for detecting HCC, with a low sensitivity for lesions
less than 1–2 cm.  CT is the most frequently used imaging technique
to evaluate patients with HCC and to survey for recurrent HCC. It
has improved sensitivity compared to US (69 vs. 60%), high speci-
ﬁcity (93%) and wide availability, and is also the preferred method
for description of anatomic relationship between the tumor and
vascular structures. The main disadvantages are accumulated radi-
ation exposure and potential nephrotoxicity of the contrast agents.
Contrast-enhanced MRI  is probably the most sensitive imaging
modality for detection of HCC, in particular for detection of intra-
hepatic disease [1]. A recent study found gadoxetic acid-enhanced
MRI  superior to multidetector CT (MDCT) in diagnostic accuracy
and detection of intrahepatic recurrent HCC [15]. Another advan-
tage of MRI  is lack of radiation exposure. Disadvantages are cost,
availability, suboptimal description of vascular structures and that
it requires a high degree of patient cooperation [1]. An important
annotation is that these ﬁndings apply to detection of intrahepatic
HCC. CT being the preferred study of choice in a total radiologic
investigation of the abdomen is generally accepted in the ﬁeld of
radiology. While MRI  is prone to artifacts due to peristalsis and
other types of movements, a CT scan now allows so rapid record-
ings that this no longer is an issue. Furthermore CT imaging allows
better geometrical reconstruction of the intraabdominal structures
than MRI. An early investigation with MRI  of the liver for intra-
hepatic HCC should nevertheless be performed to exclude primary
intrahepatic HCC.
The guidelines for management of HCC do not address the post-
operative surveillance of patients undergoing curative treatment of
HCC. A recent review article by Hatzaras et al. recommends surveil-
lance with follow-up every 3–4 months the ﬁrst 3 years. After 3
years, surveillance should be undertaken every 6–12 months. They
recommend the surveillance to include cross-sectional imaging of
the liver and measurement of serum AFP levels [1].
3. Conclusion
Ectopic HCC is a rare condition. In our patient repeated laparo-
scopic resections were feasible for HCC recurrences at varying
intraabdominal locations. We  recommend that patients with
ectopic HCC should be followed every 6 months with measurement
of AFP and abdominal CT imaging. MRI  of the liver should also be
made initially to exclude primary intrahepatic HCC.
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